X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (15) 15
humans (13) 13
female (12) 12
risk factors (10) 10
endocrinology & metabolism (7) 7
male (7) 7
middle aged (7) 7
risk (7) 7
stroke (7) 7
aged (6) 6
clinical neurology (6) 6
cryptogenic stroke (6) 6
abridged index medicus (5) 5
adult (5) 5
analysis (5) 5
aspirin (5) 5
ischemic-stroke (5) 5
pregnancy (5) 5
prevention (5) 5
blood glucose - metabolism (4) 4
cardiovascular diseases (4) 4
clinical medicine (4) 4
double-blind method (4) 4
klinisk medicin (4) 4
metaanalysis (4) 4
prevalence (4) 4
age (3) 3
anticoagulants (3) 3
aspirin - therapeutic use (3) 3
cardiac arrhythmia (3) 3
cohort studies (3) 3
embolism (3) 3
factor xa inhibitors - therapeutic use (3) 3
follow-up studies (3) 3
glucose tolerance test (3) 3
insulin resistance (3) 3
medical and health sciences (3) 3
medicin och hälsovetenskap (3) 3
neurology (3) 3
patients (3) 3
peripheral vascular disease (3) 3
platelet aggregation inhibitors - therapeutic use (3) 3
prospective studies (3) 3
resistance (3) 3
rivaroxaban (3) 3
rivaroxaban - therapeutic use (3) 3
secretion (3) 3
stroke - epidemiology (3) 3
age factors (2) 2
alfacalcidol (2) 2
atherosclerosis (2) 2
atrial fibrillation (2) 2
bleeding (2) 2
blood pressure (2) 2
blood sugar (2) 2
brain ischemia - epidemiology (2) 2
calcifediol (2) 2
cardiovascular risk (2) 2
cardiovascular-disease (2) 2
cerebral embolism (2) 2
clinical trials (2) 2
d deficiency (2) 2
design (2) 2
diabetes mellitus, type 2 - blood (2) 2
diabetes mellitus, type 2 - physiopathology (2) 2
diabetes, gestational - epidemiology (2) 2
disease progression (2) 2
dosage and administration (2) 2
embolic stroke of undetermined source (2) 2
embolisms (2) 2
glycemic index (2) 2
health aspects (2) 2
hypertension (2) 2
infant (2) 2
insulin-secreting cells - metabolism (2) 2
insulin-secreting cells - physiology (2) 2
intracranial embolism - drug therapy (2) 2
intracranial embolism - epidemiology (2) 2
ischemia (2) 2
ischemic attack, transient - epidemiology (2) 2
mellitus (2) 2
neurologi (2) 2
original research articles (2) 2
original s (2) 2
parathyroid hormone - blood (2) 2
postpartum period - physiology (2) 2
registries (2) 2
research (2) 2
sex factors (2) 2
statins (2) 2
stenosis (2) 2
stroke - drug therapy (2) 2
stroke - etiology (2) 2
studies (2) 2
thrombosis (2) 2
tolerance (2) 2
treatment outcome (2) 2
type 2 diabetes (2) 2
type-2 diabetes-mellitus (2) 2
vitamin d (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


SAE technical paper series, Volume 2015-01-2346.
From a facility perspective, engine test cells are rarely evaluated for their vibration levels in their functional configuration. When complicated dynamic... 
Test facilities | Vibration | Engines
eJournal
The New England Journal of Medicine, ISSN 0028-4793, 06/2018, Volume 378, Issue 23, pp. 2191 - 2201
In a randomized trial involving patients who had a first stroke from an embolus of unknown source, rivaroxaban at a daily dose of 15 mg did not result in a... 
CRYPTOGENIC STROKE | TRIALS | MEDICINE, GENERAL & INTERNAL | DESIGN | METAANALYSIS | EFFICACY | WARFARIN | SAFETY | ANTITHROMBOTIC THERAPY | FORAMEN OVALE CLOSURE | ATRIAL-FIBRILLATION | Stroke - prevention & control | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Brain Ischemia - prevention & control | Secondary Prevention - methods | Factor Xa Inhibitors - therapeutic use | Stroke - etiology | Rivaroxaban - adverse effects | Aspirin - adverse effects | Factor Xa Inhibitors - adverse effects | Intracranial Embolism - drug therapy | Female | Aged | Aspirin - therapeutic use | Hemorrhage - chemically induced | Platelet Aggregation Inhibitors - therapeutic use | Rivaroxaban - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Stroke (Disease) | Prevention | Rivaroxaban | Complications and side effects | Dosage and administration | Drug therapy | Hemorrhage | Risk factors | Cardiac arrhythmia | Neurosciences | Embolisms | Stenosis | Bleeding | Design | Ischemia | Atherosclerosis | Drug dosages | Research centers | Anticoagulants | Medical research | Stroke | Aspirin | Internal medicine | Research & development--R&D | Thrombosis | Patients | Embolism | Blood clots | Medicine | Neurology | Hospitals | Life Sciences | Human health and pathology | metaanalysis | atrial-fibrillation | foramen ovale closure | antithrombotic therapy | Klinisk medicin | efficacy | warfarin | Clinical Medicine | trials | safety | design | cryptogenic stroke | General & Internal Medicine
Journal Article
Circulation, ISSN 0009-7322, 11/2016, Volume 134, Issue Suppl_1 Suppl 1, pp. A18220 - A18220
IntroductionErectile dysfunction (ED) is associated with cardiovascular disease (CVD) risk factors, and predicts future CVD, suggesting that ED and... 
Journal Article
Diabetes Care, ISSN 0149-5992, 12/2014, Volume 37, Issue 12, pp. 3270 - 3278
OBJECTIVE Clinical studies evaluating the effects of medications on beta-cell function in type 2 diabetes (T2DM) are compromised by an inability to determine... 
METFORMIN | FASTING PLASMA-GLUCOSE | GLYCEMIC CONTROL | COMBINATION THERAPY | ENDOCRINOLOGY & METABOLISM | SENSITIVITY | PREVENTION | IMPAIRED GLUCOSE-TOLERANCE | MELLITUS | SECRETION | INTENSIVE INSULIN THERAPY
Journal Article
Journal Article
SAE Technical Papers, 06/2015, Volume 2015-
Journal Article
by Kasner, Scott E and Kasner, SE and Swaminathan, Balakumar and Lavados, Pablo and Lavados, P and Sharma, M and Sharma, Mukul and Muir, Keith and Muir, KW and Veltkamp, Roland and Veltkamp, R and Ameriso, Sebastian F and Ameriso, SF and Endres, M and Endres, Matthias and Lutsep, H and Lutsep, Helmi and Messé, Steven R and Spence, J David and Spence, D and Nedeltechev, Krassen and Perera, Kanjana and Perera, K and Santo, G and Santo, Gustavo and Olavarria, Veronica and Olavarria, V and Lindgren, Arne and Lindgren, A and Bangdiwala, Shrikant and Shoamanesh, Ashkan and Shoamanesh, A and Berkowitz, Scott D and Berkowitz, SD and Mundl, Hardi and Mundl, H and Connolly, Stuart J and Connolly, SJ and Hart, Robert G and Hart, RG and Abdelhamid, N and Abdul Rahman, D and Abdul-Saheb, M and Abreu, P and Abroskina, M and Abu Ahmad, F and Accassat, S and Acciaresi, M and Adami, A and Ahmad, N and Ahmed, F and Alberto Hawkes, M and Alemseged, F and Ali, A and Altavilla, R and Alwis, L and Amarenco, P and Amaro, S and Amaya Sanchez, LE and Amelia Pinto, A and Amin, H and Amino, T and Amjad, AK and Anagnostou, E and Andersen, G and Anderson, C and Anderson, DC and Andrea Falco, M and Andres Mackinnon, F and Andreu, D and Androulakis, M and Angel Gamero, M and Angel Saredo, G and Angeles Diaz, R and Angels Font, M and Anticoli, S and Arauz, A and Arauz Gongora, AA and Araya, P and Arenillas Lara, JF and Arias Rivas, S and Arnold, M and Augustin, S and Avelar, W and Azevedo, E and Babikian, V and Bacellar, A and Badalyan, K and Bae, HJ and Baez Martinez, EM and Bagelmann, H and Bailey, P and Bak, Z and Baker, M and Balazs, A and Baldaranov, D and Balogun, I and Balueva, T and Bankuti, Z and Bar, M and ... and NAVIGATE ESUS Investigators and Klinisk strokeforskning and EpiHealth: Epidemiology for Health and Clinical Stroke Research Group and Lund University and Lunds universitet
The Lancet Neurology, ISSN 1474-4422, 12/2018, Volume 17, Issue 12, pp. 1053 - 1060
Journal Article